Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 578

1.

Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice.

Zhao Y, Keshiya S, Atashrazm F, Gao J, Ittner LM, Alessi DR, Halliday GM, Fu Y, Dzamko N.

Neurobiol Dis. 2018 Sep 5;120:76-87. doi: 10.1016/j.nbd.2018.09.003. [Epub ahead of print]

2.

Reply: Will FTLD-tau work for all when FTDP-17 retires?

Forrest SL, Kril JJ, Halliday GM.

Brain. 2018 Jun 26. doi: 10.1093/brain/awy179. [Epub ahead of print] No abstract available.

PMID:
29947744
3.

Melanoma protective antitumor immunity activated by catalytic DNA.

Cai H, Cho EA, Li Y, Sockler J, Parish CR, Chong BH, Edwards J, Dodds TJ, Ferguson PM, Wilmott JS, Scolyer RA, Halliday GM, Khachigian LM.

Oncogene. 2018 Sep;37(37):5115-5126. doi: 10.1038/s41388-018-0306-0. Epub 2018 May 29.

PMID:
29844573
4.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

PMID:
29724592
5.

Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice.

van Hummel A, Chan G, van der Hoven J, Morsch M, Ippati S, Suh L, Bi M, Asih PR, Lee WS, Butler TA, Przybyla M, Halliday GM, Piguet O, Kiernan MC, Chung RS, Ittner LM, Ke YD.

Am J Pathol. 2018 Jun;188(6):1447-1456. doi: 10.1016/j.ajpath.2018.03.002. Epub 2018 Mar 22.

PMID:
29577934
6.

Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development.

Kim WS, Jary E, Pickford R, He Y, Ahmed RM, Piguet O, Hodges JR, Halliday GM.

Front Neurol. 2018 Feb 28;9:104. doi: 10.3389/fneur.2018.00104. eCollection 2018.

7.

Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration.

Shepherd CE, Yang Y, Halliday GM.

Neuroscience. 2018 Mar 15;374:326-334. doi: 10.1016/j.neuroscience.2018.01.050. Epub 2018 Feb 9. Review.

8.

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.

Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J.

Lancet Neurol. 2018 Jan;17(1):64-74. doi: 10.1016/S1474-4422(17)30400-3. Epub 2017 Dec 16.

9.

Enhanced Repair of UV-Induced DNA Damage by 1,25-Dihydroxyvitamin D3 in Skin Is Linked to Pathways that Control Cellular Energy.

Rybchyn MS, De Silva WGM, Sequeira VB, McCarthy BY, Dilley AV, Dixon KM, Halliday GM, Mason RS.

J Invest Dermatol. 2018 May;138(5):1146-1156. doi: 10.1016/j.jid.2017.11.037. Epub 2017 Dec 16.

PMID:
29258892
10.

Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.

Burrell JR, Ballard KJ, Halliday GM, Hodges JR.

J Alzheimers Dis. 2018;61(2):705-715. doi: 10.3233/JAD-170743.

PMID:
29254097
11.

Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition.

Ahmed RM, Highton-Williamson E, Caga J, Thornton N, Ramsey E, Zoing M, Kim WS, Halliday GM, Piguet O, Hodges JR, Farooqi IS, Kiernan MC.

J Alzheimers Dis. 2018;61(2):773-783. doi: 10.3233/JAD-170660.

PMID:
29254092
12.

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC, Götz J, Spillantini MG, Hodges JR, Ittner LM, Halliday GM.

Brain. 2018 Feb 1;141(2):521-534. doi: 10.1093/brain/awx328.

13.

Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers.

Zhao Y, Perera G, Takahashi-Fujigasaki J, Mash DC, Vonsattel JPG, Uchino A, Hasegawa K, Jeremy Nichols R, Holton JL, Murayama S, Dzamko N, Halliday GM.

Brain. 2018 Feb 1;141(2):486-495. doi: 10.1093/brain/awx344.

14.

Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration.

Tan RH, Yang Y, Halliday GM.

Neuropathol Appl Neurobiol. 2017 Dec 7. doi: 10.1111/nan.12455. [Epub ahead of print]

PMID:
29215728
15.

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.

Tan RH, Yang Y, Kim WS, Dobson-Stone C, Kwok JB, Kiernan MC, Halliday GM.

Acta Neuropathol Commun. 2017 Oct 27;5(1):76. doi: 10.1186/s40478-017-0480-2.

16.

Accumulation of dysfunctional SOD1 protein in Parkinson's disease is not associated with mutations in the SOD1 gene.

Trist BG, Fifita JA, Freckleton SE, Hare DJ, Lewis SJG, Halliday GM, Blair IP, Double KL.

Acta Neuropathol. 2018 Jan;135(1):155-156. doi: 10.1007/s00401-017-1779-6. Epub 2017 Oct 19. No abstract available.

PMID:
29052003
17.

α-Synuclein Regulates Neuronal Cholesterol Efflux.

Hsiao JT, Halliday GM, Kim WS.

Molecules. 2017 Oct 19;22(10). pii: E1769. doi: 10.3390/molecules22101769.

18.

Parkinson's Disease Is Not Simply a Prion Disorder.

Surmeier DJ, Obeso JA, Halliday GM.

J Neurosci. 2017 Oct 11;37(41):9799-9807. doi: 10.1523/JNEUROSCI.1787-16.2017. Review.

19.

Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.

Genoud S, Roberts BR, Gunn AP, Halliday GM, Lewis SJG, Ball HJ, Hare DJ, Double KL.

Metallomics. 2017 Oct 18;9(10):1447-1455. doi: 10.1039/c7mt00244k.

PMID:
28944802
20.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

21.

MSA prions exhibit remarkable stability and resistance to inactivation.

Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A, Mordes DA, Halliday GM, Middleton LT, Gentleman SM, Olson SH, Prusiner SB.

Acta Neuropathol. 2018 Jan;135(1):49-63. doi: 10.1007/s00401-017-1762-2. Epub 2017 Aug 28.

22.

Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.

Surmeier DJ, Halliday GM, Simuni T.

Exp Neurol. 2017 Dec;298(Pt B):202-209. doi: 10.1016/j.expneurol.2017.08.001. Epub 2017 Aug 2. Review.

PMID:
28780195
23.

Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?

Minocha R, Damian DL, Halliday GM.

Photodermatol Photoimmunol Photomed. 2018 Jan;34(1):5-12. doi: 10.1111/phpp.12328. Epub 2017 Aug 8. Review.

PMID:
28681504
24.

Clinical Aspects of Alzheimer's Disease.

Kumfor F, Halliday GM, Piguet O.

Adv Neurobiol. 2017;15:31-53. doi: 10.1007/978-3-319-57193-5_2.

PMID:
28674977
25.

Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes.

Tan RH, Kril JJ, Yang Y, Tom N, Hodges JR, Villemagne VL, Rowe CC, Leyton CE, Kwok JBJ, Ittner LM, Halliday GM.

Alzheimers Dement (Amst). 2017 May 29;9:10-20. doi: 10.1016/j.dadm.2017.05.005. eCollection 2017.

26.

Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia With Lewy Bodies.

Szeto JYY, Halliday GM, Naismith SL, Lewis SJG.

J Geriatr Psychiatry Neurol. 2017 Jul;30(4):196-205. doi: 10.1177/0891988717711451.

PMID:
28639878
27.

Early-life decline in neurogenesis markers and age-related changes of TrkB splice variant expression in the human subependymal zone.

Weissleder C, Kondo MA, Yang C, Fung SJ, Rothmond DA, Wong MW, Halliday GM, Herman MM, Kleinman JE, Webster MJ, Shannon Weickert C.

Eur J Neurosci. 2017 Jul;46(2):1768-1778. doi: 10.1111/ejn.13623. Epub 2017 Jul 7.

PMID:
28612959
28.

Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).

Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, Budka H, Dickson DW, Dugger BN, Duyckaerts C, Ferrer I, Forrest SL, Gelpi E, Gentleman SM, Giaccone G, Grinberg LT, Halliday GM, Hatanpaa KJ, Hof PR, Hofer M, Hortobágyi T, Ironside JW, King A, Kofler J, Kövari E, Kril JJ, Love S, Mackenzie IR, Mao Q, Matej R, McLean C, Munoz DG, Murray ME, Neltner J, Nelson PT, Ritchie D, Rodriguez RD, Rohan Z, Rozemuller A, Sakai K, Schultz C, Seilhean D, Smith V, Tacik P, Takahashi H, Takao M, Rudolf Thal D, Weis S, Wharton SB, White CL 3rd, Woulfe JM, Yamada M, Trojanowski JQ.

J Neuropathol Exp Neurol. 2017 Jul 1;76(7):605-619. doi: 10.1093/jnen/nlx041.

29.

Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson's disease brain.

Trist BG, Davies KM, Cottam V, Genoud S, Ortega R, Roudeau S, Carmona A, De Silva K, Wasinger V, Lewis SJG, Sachdev P, Smith B, Troakes C, Vance C, Shaw C, Al-Sarraj S, Ball HJ, Halliday GM, Hare DJ, Double KL.

Acta Neuropathol. 2017 Jul;134(1):113-127. doi: 10.1007/s00401-017-1726-6. Epub 2017 May 19.

PMID:
28527045
30.

The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.

Silsby M, Tweedie-Cullen RY, Murray CR, Halliday GM, Hodges JR, Burrell JR.

Eur J Neurol. 2017 Jul;24(7):956-965. doi: 10.1111/ene.13314. Epub 2017 May 16.

PMID:
28510312
31.

von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion.

Yang Y, Halliday GM, Hodges JR, Tan RH.

J Alzheimers Dis. 2017;58(3):701-709. doi: 10.3233/JAD-170002.

PMID:
28482638
32.

Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.

Van Langenhove T, Piguet O, Burrell JR, Leyton C, Foxe D, Abela M, Bartley L, Kim WS, Jary E, Huang Y, Dobson-Stone C, Kwok JB, Halliday GM, Hodges JR.

J Alzheimers Dis. 2017;58(1):163-170. doi: 10.3233/JAD-161272.

PMID:
28387671
33.

Parkinson disease.

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE.

Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13. Review.

PMID:
28332488
34.

The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion.

Devenney EM, Landin-Romero R, Irish M, Hornberger M, Mioshi E, Halliday GM, Kiernan MC, Hodges JR.

Neuroimage Clin. 2016 Dec 2;13:439-445. doi: 10.1016/j.nicl.2016.11.028. eCollection 2017.

35.

Selective neuronal vulnerability in Parkinson disease.

Surmeier DJ, Obeso JA, Halliday GM.

Nat Rev Neurosci. 2017 Jan 20;18(2):101-113. doi: 10.1038/nrn.2016.178. Review.

36.

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.

Purves-Tyson TD, Owens SJ, Rothmond DA, Halliday GM, Double KL, Stevens J, McCrossin T, Shannon Weickert C.

Transl Psychiatry. 2017 Jan 17;7(1):e1003. doi: 10.1038/tp.2016.257.

37.

Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology.

Ahmed RM, Irish M, van Eersel J, Ittner A, Ke YD, Volkerling A, van der Hoven J, Tanaka K, Karl T, Kassiou M, Kril JJ, Piguet O, Götz J, Kiernan MC, Halliday GM, Hodges JR, Ittner LM.

Neurosci Biobehav Rev. 2017 Mar;74(Pt A):126-138. doi: 10.1016/j.neubiorev.2017.01.004. Epub 2017 Jan 11. Review.

PMID:
28088537
38.

ALS/FTLD: experimental models and reality.

Tan RH, Ke YD, Ittner LM, Halliday GM.

Acta Neuropathol. 2017 Feb;133(2):177-196. doi: 10.1007/s00401-016-1666-6. Epub 2017 Jan 5. Review.

PMID:
28058507
39.

Damaging Effects of Ultraviolet Radiation on the Cornea.

Delic NC, Lyons JG, Di Girolamo N, Halliday GM.

Photochem Photobiol. 2017 Jul;93(4):920-929. doi: 10.1111/php.12686. Epub 2017 Feb 28. Review.

PMID:
27935054
40.

Decline in Proliferation and Immature Neuron Markers in the Human Subependymal Zone during Aging: Relationship to EGF- and FGF-Related Transcripts.

Weissleder C, Fung SJ, Wong MW, Barry G, Double KL, Halliday GM, Webster MJ, Weickert CS.

Front Aging Neurosci. 2016 Nov 25;8:274. eCollection 2016.

41.

LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.

Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y, Takao M, Wauters S, van de Berg WD, Takahashi-Fujigasaki J, Nichols RJ, Holton JL, Murayama S, Halliday GM.

Mov Disord. 2017 Mar;32(3):423-432. doi: 10.1002/mds.26892. Epub 2016 Dec 2.

PMID:
27911006
42.

Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.

Kordower JH, Goetz CG, Chu Y, Halliday GM, Nicholson DA, Musial TF, Marmion DJ, Stoessl AJ, Sossi V, Freeman TB, Olanow CW.

Ann Neurol. 2017 Jan;81(1):46-57. doi: 10.1002/ana.24820. Epub 2017 Jan 6.

43.

Authors' response to a reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.

Damian DL, Martin AJ, Scolyer RA, Chen AC, Halliday GM.

Br J Dermatol. 2017 Feb;176(2):552-553. doi: 10.1111/bjd.15204. Epub 2017 Jan 25. No abstract available.

PMID:
27893156
44.

Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.

Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J, Fu Y, Halliday GM.

Acta Neuropathol. 2017 Feb;133(2):303-319. doi: 10.1007/s00401-016-1648-8. Epub 2016 Nov 25.

45.

Increased aneuploidy is not a universal feature across α-synucleinopathies.

Yang Y, Shepherd CE, Halliday GM.

Mov Disord. 2017 Mar;32(3):475-476. doi: 10.1002/mds.26869. Epub 2016 Nov 10. No abstract available.

PMID:
27862335
46.

ROCK1 Is Associated with Alzheimer's Disease-Specific Plaques, as well as Enhances Autophagosome Formation But not Autophagic Aβ Clearance.

Hu YB, Zou Y, Huang Y, Zhang YF, Lourenco GF, Chen SD, Halliday GM, Wang G, Ren RJ.

Front Cell Neurosci. 2016 Nov 2;10:253. eCollection 2016.

47.

A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients.

Chen AC, Martin AJ, Dalziell RA, McKenzie CA, Lowe PM, Eris JM, Scolyer RA, Dhillon HM, Vardy JL, Bielski VA, Halliday GM, Damian DL.

Br J Dermatol. 2016 Nov;175(5):1073-1075. doi: 10.1111/bjd.14662. Epub 2016 Aug 10. No abstract available.

PMID:
27061568
48.

Characterization of circular RNAs landscape in multiple system atrophy brain.

Chen BJ, Mills JD, Takenaka K, Bliim N, Halliday GM, Janitz M.

J Neurochem. 2016 Nov;139(3):485-496. doi: 10.1111/jnc.13752. Epub 2016 Sep 5.

49.

Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.

Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, Holstege H, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Clarimon J, Lleó A, Morenas-Rodríguez E, Lesage S, Galasko D, Masliah E, Santana I, Diez M, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Stone DJ, Pickering-Brown S, Mann D, Dickson DW, Halliday GM, Singleton A, Guerreiro R, Bras J.

Neurobiol Aging. 2017 Jan;49:214.e13-214.e15. doi: 10.1016/j.neurobiolaging.2016.08.023. Epub 2016 Sep 2.

50.

Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.

Matrone C, Dzamko N, Madsen P, Nyegaard M, Pohlmann R, Søndergaard RV, Lassen LB, Andresen TL, Halliday GM, Jensen PH, Nielsen MS.

PLoS One. 2016 Aug 10;11(8):e0160501. doi: 10.1371/journal.pone.0160501. eCollection 2016.

Supplemental Content

Loading ...
Support Center